Time trends in pediatric hospitalizations for hepatitis A in Greece (1999–2013): Assessment of the impact of universal infant immunization in 2008
Ημερομηνία
2016Γλώσσα
en
Λέξη-κλειδί
Επιτομή
ABSTRACT: Hepatitis A vaccine was introduced in the Greek National Immunization Program in 2008. To estimate possible impact of the universal vaccination implementation, time trends of hospitalizations for hepatitis A at the Infectious Diseases Unit of a Tertiary Pediatric Hospital in Athens during 1999–2013 were analyzed. Hepatitis A hospitalizations were recorded from the discharge database and were expressed as frequencies and rate of annual departmental hospitalizations. Time series analysis (ARIMA) was used to explore trends and the impact of the vaccination. Moreover, changes in patient age, population group distribution and the duration of hospitalization were also examined. Hepatitis A hospitalizations rate significantly decreased between pre-vaccination (1999–2008) and post-vaccination (2009–2013) era from 50.5 to 20.8/1000 hospitalizations (p = 0.005). A 3-year periodicity and a trend of reduction on hepatitis A hospitalizations rates across years were noted. Roma children had significant higher rates of hepatitis A hospitalization, followed by immigrant children. Importantly, possibly due to preceding vaccine availability with considerable uptake in private market and unvaccinated group/pockets of children (Roma), overall vaccination effect was less apparent when compared to data from other countries that implemented universal vaccination. No significant change in patient age, population group distribution, or duration of hospitalization was observed. High risk groups such as Roma children should be targeted for vaccination to reduce future outbreaks. © 2016 Taylor & Francis.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Hepatitis a outbreak disproportionately affecting men who have sex with men (MSM) in the european union and european economic area, june 2016 to may 2017
Ndumbi P., Freidl G.S., Williams C.J., Mårdh O., Varela C., Avellón A., Friesema I., Vennema H., Beebeejaun K., Ngui S.L., Edelstein M., Smith-Palmer A., Murphy N., Dean J., Faber M., Wenzel J., Kontio M., Müller L., Midgley S.E., Sundqvist L., Ederth J.L., Roque-Afonso A.-M., Couturier E., Klamer S., Rebolledo J., Suin V., Aberle S.W., Schmid D., De Sousa R., Augusto G.F., Alfonsi V., Del Manso M., Ciccaglione A.R., Mellou K., Hadjichristodoulou C., Donachie A., Borg M.-L., Sočan M., Poljak M., Severi E., Parmentier S., Laisnez V., Reynaerts A., Mahieu R., Schirvel C., Vestergaard H.T., Nisavanh A., Jessen H., Michaelis K., Sissolak D., Thoulass J., Zimmermann R., Thornton L., Martinelli D., Cappelli M.G., Del Matto G., Chironna M., Bruni R., Borg M.-L., Aldir I., Nascimento M., Martins A., Aguiar B., Medina D., Fafangel M., Skaza A.T., Marinko J.S., Stojanovič D., Kurinčič T.S., Montaño-Remacha C., Fernandez M.G., Gomez-Barroso D., Vazquez S., Reyes N., Mandal S., Balogun K., Spiteri G., Takkinen J., Amato A., European Hepatitis A Outbreak Investigation Team (2018)Between 1 June 2016 and 31 May 2017, 17 European Union (EU) and European Economic Area countries reported 4,096 cases associated with a multi-country hepatitis A (HA) outbreak. Molecular analysis identified three co-circulating ... -
Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)
Wranke A., Pinheiro Borzacov L.M., Parana R., Lobato C., Hamid S., Ceausu E., Dalekos G.N., Rizzetto M., Turcanu A., Niro G.A., Lubna F., Abbas M., Ingiliz P., Buti M., Ferenci P., Vanwolleghem T., Hayden T., Dashdorj N., Motoc A., Cornberg M., Abbas Z., Yurdaydin C., Manns M.P., Wedemeyer H., Hardtke S., Serrano B., Wöbse M., Heidrich B., Muche M., Gatselis N., Zachou K., Ho E., Smedile A., Fontana R., Gish R., Obretin D., Stern R., the Hepatitis Delta International Network (2018)Background & Aims: Chronic hepatitis D (delta) is a major global health burden. Clinical and virological characteristics of patients with hepatitis D virus (HDV) infection and treatment approaches in different regions ... -
HBeAg-positive hepatitis delta: Virological patterns and clinical long-term outcome
Heidrich, B.; C. Serrano, B.; Idilman, R.; Kabaçam, G.; Bremer, B.; Raupach, R.; Önder, F. O.; Deterding, K.; Zacher, B. J.; Taranta, A.; Bozkaya, H.; Zachou, K.; Tillmann, H. L.; Bozdayi, A. M.; Manns, M. P.; Yurdaydin, C.; Wedemeyer, H. (2012)Background and Aims: The presence of the hepatitis B virus (HBV)-eAg in patients with hepatitis B is associated with higher HBV replication and with an increased risk to develop liver-related clinical endpoints defined as ...